检索结果-南通市图书馆

Unique situation of hepatocellular carcinoma in Egypt:A review of epidemiology and control measures

World Journal of Gastrointestinal Oncology 2021年第12期13卷 1919-1938页

作者： Reem Ezzat mohamed eltabbakh mohamed El Kassas Internal Medicine Department Faculty of MedicineAssiut UniversityAssiut 71515Egypt Tropical Medicine Department Faculty of MedicineAin Shams UniversityCairo 11566Egypt Endemic Medicine Department Faculty of MedicineHelwan UniversityCairo 11795CairoEgypt

Hepatocellular carcinoma(HCC)is the sixth most common primary malignancy worldwide,and the third most common cause of death among cancers *** occurs in several pre-existing conditions,including hepatitis C,hepatitis B virus,and non-alcoholic *** used to be the country with the heaviest hepatitis C virus(HCV)*** relationship between HCV and HCC is an important research *** Egypt,HCC is a significant public health problem.A possible cause for the increasing rates of detection of HCC in Egypt is the mass screening program that was carried by the government for detecting and treating HCV.A multidisciplinary approach is now widely applied to HCC management in health centers all over *** treatment modalities are available in Egypt,with success rates comparable to global *** Egyptian health authorities have made the elimination of HCV from Egypt a special priority,and this approach should lead to a decrease in number of HCC cases in the near *** this article we review the current situation of HCC in Egypt,including epidemiological aspects,relevant risk factors for HCC development,strategies,and efforts established by health authorities for the screening and prevention of both HCV and HCC in *** highlight the different modalities for HCC treatment.

关键词： Hepatocellular carcinoma Liver cancer Hepatitis C virus Hepatitis B virus Screening Egypt

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Comparative study between bowel ultrasound and magnetic resonance enterography among Egyptian inflammatory bowel disease patients

引用

World Journal of Gastroenterology 2020年第38期26卷 5884-5895页

作者： Shimaa Kamel mohamed Sakr Waleed Hamed mohamed eltabbakh Safaa Askar Ahmed Bassuny Rasha Hussein Ahmed Elbaz Department of Tropical Medicine Gastroenterology and HepatologyAin Shams UniversityCairo 11566Egypt Department of Radiology Ain Shams University and MR Unit of Misr Radiology CenterCairo 11566Egypt

BACKGROUND Bowel ultrasound and magnetic resonance enterography(MRE)are decisive medical imaging modalities for diagnosing and locating bowel lesions with its extramural extent and *** assess the degree of activity,help clinicians to identify patients in need of surgery,and can be used for patient *** To compare the role of MRE and bowel ultrasound in diagnosis and follow-up of inflammatory bowel disease(IBD)patients in *** The study was conducted on 40 patients with *** patients were subjected to clinical assessment,laboratory investigations,bowel ultrasound,MRE,and colonoscopy up to the terminal ileum with biopsies for histopathological *** This study was conducted on 14 patients(35%)with ulcerative colitis and 26 patients(65%)with Crohn's disease;34(85%)of these patients had active *** ultrasound detected different bowel lesions with the following accuracies:ileum(85%),large bowel(70%),fistula(95%),stricture and proximal dilatation(95%)and abscesses(100%).Also,it showed that statistically significance of bowel ultrasound in differentiation between remission and activity of IBD in comparison to MRE and *** In comparison to MRE,bowel ultrasound is a useful,non-invasive,and feasible bedside imaging tool for the detection of inflammation,detection of complications,and follow-up of IBD patients when performed by the attending physician.

关键词： Bowel ultrasound Colonoscopy Crohn's disease Magnetic resonance enterography Ulcerative colitis Inflammatory bowel disease

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Non-pulmonary involvement in COVID-19:A systemic disease rather than a pure respiratory infection

引用

World Journal of Clinical Cases 2023年第3期11卷 493-505页

作者： mohamed El-Kassas mohamed Alboraie mohamed Elbadry Reem El Sheemy mohamed Abdellah Shimaa Afify Ahmad Madkour Mariam Zaghloul Abeer Awad mohamed-Naguib Wifi Amira Al Balakosy mohamed eltabbakh Department of Endemic Medicine Faculty of MedicineHelwan UniversityCairo 11731Egypt Department of Internal Medicine Al-Azhar UniversityCairo 11884Egypt Department of Tropical Medicine Minia Faculty of MedicineMinia UniversityMinia 61511Egypt Department of Gastroenterology National Hepatology and Tropical Medicine Research InstituteCairo 11451Egypt Department of Hepatology Gastroenterology and Infectious DiseasesFaculty of MedicineKafrelsheikh UniversityKafrelsheikh 33511Egypt Department of Internal Medicine Hepatogastroenterology UnitKasr Al-Ainy School of MedicineCairo 11451Egypt Department of Tropical Medicine Ain Shams UniversityCairo 11451Egypt

During the early phase of the coronavirus disease 2019(COVID-19)pandemic caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),diagnosis was difficult due to the diversity in symptoms and imaging findings and the variability of disease *** manifestations are reportedly the main clinical presentations of COVID-19 *** are working hard on a myriad of clinical,epidemiological,and biological aspects to better understand SARS-CoV-2 infection,aiming to mitigate the ongoing *** reports have documented the involvement of various body systems and organs apart from the respiratory tract including the gastrointestinal,liver,immune system,renal,and neurological *** involvement will result in diverse presentations related to effects on these *** presentations such as coagulation defects and cutaneous manifestation may also *** with specific comorbidities including obesity,diabetes,and hypertension have increased morbidity and mortality risks with COVID-19.

关键词： COVID-19 Non-pulmonary Extrapulmonary Clinical manifestations Systemic disease

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Towards hepatitis C virus elimination:Egyptian experience,achievements and limitations

引用

World Journal of Gastroenterology 2018年第38期24卷 4330-4340页

作者： Dalia Omran mohamed Alboraie Rania A Zayed mohamed-Naguib Wifi Mervat Naguib mohamed eltabbakh mohamed Abdellah Ahmed Fouad Sherief Sahar Maklad Heba Hamdy Eldemellawy Omar Khalid Saad Doaa mohamed Khamiss mohamed El Kassas Department of Endemic Medicine and Hepatology Faculty of MedicineCairo UniversityCairo 11651Egypt Department of Endemic Medicine Faculty of MedicineHelwan UniversityCairo 11599Egypt Department of Internal Medicine Al-Azhar UniversityCairo 11651Egypt Department of Clinical and Chemical Pathology Faculty of MedicineCairo UniversityCairo 11651Egypt Department of Internal Medicine Faculty of MedicineCairo UniversityCairo 11599Egypt Department of Tropical Medicine Faculty of MedicineAin Shams UniversityCairo 11566Egypt National Hepatology and Tropical Medicine Research Institute Cairo 11599Egypt Department of Internal Medicine Faculty of MedicineBeni-Suef UniversityBeni-Suef 62511Egypt Faculty of Medicine Ain Shams UniversityCairo 11566Egypt Department of Clinical and Chemical Pathology El-monera hospitalMinistry of HealthCairo 11562Egypt

Worldwide, more than one million people die each year from hepatitis C virus(HCV) related diseases, and over 300 million people are chronically infected with hepatitis B or C. Egypt used to be on the top of the countries with heavy HCV burden. Some countries are making advances in elimination of HCV, yet multiple factors preventing progress; remain for the majority. These factors include lack of global funding sources for treatment, late diagnosis, poor data, and inadequate screening. Treatment of HCV in Egypt has become one of the top national priorities since 2007. Egypt started a national treatment program intending to provide cure for Egyptian HCV-infected patients. Mass HCV treatment program had started using Pegylated interferon and ribavirin between 2007 and 2014. Yet, with the development of highly-effective direct acting antivirals(DAAs) for HCV, elimination of viral hepatitis has become a real possibility. The Egyptian National Committee for the Control of Viral Hepatitis did its best to provide Egyptian HCV patients with DAAs. Egypt adopted a strategy that represents a model of care that could help other countries with high HCV prevalence rate in their battle against HCV. This review covers the effects of HCV management in Egyptian real life settings and the outcome of different treatment protocols. Also, it deals with the current and future strategies for HCV prevention and screening as well as the challenges facing HCV elimination and the prospect of future eradication of HCV.

关键词： Hepatitis C virus Egypt Direct acting antivirals screening elimination Limitations

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：